Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IE | CPRI |
|---|---|---|
| Price | $10.33 | $14.49 |
| Change today | ▼ 1.05% | ▲ 0.35% |
| Market cap | $1.65B | $1.65B |
| Return, 3 months | +13.0% | -25.4% |
| Return, year to date | -35.4% | -40.6% |
| Return, 1 year | -15.3% | -31.6% |
| P/E (TTM) | -7.8 | 11.1 |
| P/B | 3.1 | 11.9 |
| P/E percentile vs own 5y | – | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +83.9% | +39.3% |
| Analyst buy share | 100% | 45% |
| RSI (14) | 51 | 50 |
| 30-day volatility | 73.5% | 46.8% |
| Max drawdown, 1 year | -59.4% | -54.0% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
